Tacrolimus + steroids, monoclonal anti-IL2R antibody
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hepatitis C
Conditions
Hepatitis C, Liver Transplantation
Trial Timeline
Jun 1, 2005 → Jun 1, 2008
NCT ID
NCT00295607About Tacrolimus + steroids, monoclonal anti-IL2R antibody
Tacrolimus + steroids, monoclonal anti-IL2R antibody is a phase 2 stage product being developed by Astellas Pharma for Hepatitis C. The current trial status is completed. This product is registered under clinical trial identifier NCT00295607. Target conditions include Hepatitis C, Liver Transplantation.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00295607 | Phase 2 | Completed |
Competing Products
20 competing products in Hepatitis C
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| VK2809 + Placebos | Viking Therapeutics | Phase 2 | 47 |
| TERN-501 + TERN-101 | Terns Pharmaceuticals | Phase 2 | 49 |
| TERN-101 | Terns Pharmaceuticals | Phase 2 | 49 |
| TERN-201 | Terns Pharmaceuticals | Phase 1 | 30 |
| IVA337 + IVA337 + Placebo | Inventiva | Phase 2 | 47 |
| IVA337 + Placebo + Empagliflozin | Inventiva | Phase 2 | 47 |
| IVA337 + Placebo | Inventiva | Phase 3 | 72 |
| Pegasys® + Pegasys® | Chugai Pharmaceutical | Approved | 85 |
| peginterferon alfa-2a + rivavirin | Chugai Pharmaceutical | Phase 3 | 77 |
| SOF + COPE | Chugai Pharmaceutical | Pre-clinical | 23 |
| Colesevelam Hcl | Daiichi Sankyo | Phase 2 | 52 |
| ASP9831 + Placebo | Astellas Pharma | Phase 2 | 52 |
| FK788 | Astellas Pharma | Phase 2 | 52 |
| MK-2248 | Merck | Phase 1 | 33 |
| Interferon alfacon-1 | Astellas Pharma | Phase 3 | 77 |
| Pegylated Interferon + Ribavirin | Astellas Pharma | Approved | 85 |
| Dolutegravir + Rlipivirine + GSK1265744 | Shionogi | Phase 1 | 33 |
| Dolutegravir + Methadone | Shionogi | Phase 1 | 33 |
| Clevudine + Adefovir | Eisai | Phase 3 | 77 |
| KRN7000 | Kyowa Kirin | Phase 1/2 | 41 |